SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration

Mar 15 2024
New Multimodal Algorithm Highlights Predictive Benefit Of Artificial Intelligence (AI) for Cancer Research BOSTON and ROLLE, Switzerland , March 15, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, and the French Kidney

Read more

Build something bigger than your career

Enjoyed learning about life at SOPHiA from our blogs? Here are a few of our open roles

Title Country Department
Junior Sales Operations Specialist Intern France Clinical Sales
Junior Bioinformation Intern - Tertiary Analysis Switzerland Data Science
Junior Customer Services Specialist Intern Switzerland Clinical Sales
Accounts Payable Accountant France Finance
NGS Sales Manager - ANZ Australia Clinical Sales